I-MAB Analyst Ratings
I-MAB Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/18/2023 | 943.48% | Needham | → $24 | Reiterates | Buy → Buy |
06/05/2023 | 943.48% | Needham | → $24 | Reiterates | Buy → Buy |
04/19/2023 | 943.48% | Needham | → $24 | Reiterates | → Buy |
04/03/2023 | 943.48% | Needham | $33 → $24 | Maintains | Buy |
04/03/2023 | 986.96% | Piper Sandler | $30 → $25 | Maintains | Overweight |
04/03/2023 | 986.96% | HC Wainwright & Co. | $45 → $25 | Maintains | Buy |
08/31/2022 | 1856.52% | HC Wainwright & Co. | $70 → $45 | Maintains | Buy |
08/31/2022 | 1334.78% | Needham | $41 → $33 | Maintains | Buy |
08/30/2022 | 1204.35% | Piper Sandler | $35 → $30 | Maintains | Overweight |
08/17/2022 | 1682.61% | Needham | $72 → $41 | Maintains | Buy |
05/31/2022 | 2943.48% | HC Wainwright & Co. | $80 → $70 | Maintains | Buy |
05/31/2022 | 3030.43% | Needham | $85 → $72 | Maintains | Buy |
03/30/2022 | 3378.26% | HC Wainwright & Co. | $95 → $80 | Maintains | Buy |
11/01/2021 | 3595.65% | Needham | $83 → $85 | Maintains | Buy |
09/01/2021 | 4030.43% | HC Wainwright & Co. | $75 → $95 | Maintains | Buy |
06/10/2021 | 3813.04% | Cantor Fitzgerald | $76 → $90 | Maintains | Overweight |
06/02/2021 | — | Daiwa Capital | Initiates Coverage On | → Buy | |
03/15/2021 | 3160.87% | Needham | → $75 | Initiates Coverage On | → Buy |
03/03/2021 | 3160.87% | H.C. Wainwright | $55 → $75 | Maintains | Buy |
02/25/2021 | 3160.87% | Piper Sandler | → $75 | Initiates Coverage On | → Overweight |
12/07/2020 | 2291.3% | HC Wainwright & Co. | → $55 | Initiates Coverage On | → Buy |
08/26/2020 | 1695.65% | CMB International | → $41.3 | Initiates Coverage On | → Buy |
07/27/2020 | 2073.91% | Cantor Fitzgerald | → $50 | Initiates Coverage On | → Overweight |
02/14/2020 | 686.52% | CICC | → $18.09 | Initiates Coverage On | → Outperform |
02/12/2020 | 679.57% | China Renaissance | → $17.93 | Initiates Coverage On | → Buy |
02/11/2020 | 595.65% | Jefferies | → $16 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
08/18/2023 | 943.48% | 尼德姆 | → 24 美元 | 重申 | 購買 → 購買 |
06/05/2023 | 943.48% | 尼德姆 | → 24 美元 | 重申 | 購買 → 購買 |
04/19/2023 | 943.48% | 尼德姆 | → 24 美元 | 重申 | → 購買 |
04/03/2023 | 943.48% | 尼德姆 | 33 美元 → 24 美元 | 維護 | 購買 |
04/03/2023 | 986.96% | 派珀·桑德勒 | 30 美元 → 25 美元 | 維護 | 超重 |
04/03/2023 | 986.96% | HC Wainwright & Co. | 45 美元 → 25 美元 | 維護 | 購買 |
08/31/2022 | 1856.52% | HC Wainwright & Co. | 70 美元 → 45 美元 | 維護 | 購買 |
08/31/2022 | 1334.78% | 尼德姆 | 41 美元 → 33 美元 | 維護 | 購買 |
08/30/2022 | 1204.35% | 派珀·桑德勒 | 35 美元 → 30 美元 | 維護 | 超重 |
08/17/2022 | 1682.61% | 尼德姆 | 72 美元 → 41 美元 | 維護 | 購買 |
05/31/2022 | 2943.48% | HC Wainwright & Co. | 80 美元 → 70 美元 | 維護 | 購買 |
05/31/2022 | 3030.43% | 尼德姆 | 85 美元 → 72 美元 | 維護 | 購買 |
03/30/2022 | 3378.26% | HC Wainwright & Co. | 95 美元 → 80 美元 | 維護 | 購買 |
11/01/2021 | 3595.65% | 尼德姆 | 83 美元 → 85 美元 | 維護 | 購買 |
09/01/2021 | 4030.43% | HC Wainwright & Co. | 75 美元 → 95 美元 | 維護 | 購買 |
06/10/2021 | 3813.04% | 坎託·菲茨傑拉德 | 76 美元 → 90 美元 | 維護 | 超重 |
06/02/2021 | — | 大和資本 | 啓動覆蓋開啓 | → 購買 | |
2021 年 3 月 15 日 | 3160.87% | 尼德姆 | → 75 美元 | 啓動覆蓋開啓 | → 購買 |
03/03/2021 | 3160.87% | H.C. Wainwright | 55 美元 → 75 美元 | 維護 | 購買 |
2021 年 2 月 25 日 | 3160.87% | 派珀·桑德勒 | → 75 美元 | 啓動覆蓋開啓 | → 超重 |
12/07/2020 | 2291.3% | HC Wainwright & Co. | → 55 美元 | 啓動覆蓋開啓 | → 購買 |
08/26/2020 | 1695.65% | 招商銀行國際 | → 41.3 美元 | 啓動覆蓋開啓 | → 購買 |
07/27/2020 | 2073.91% | 坎託·菲茨傑拉德 | → 50 美元 | 啓動覆蓋開啓 | → 超重 |
02/14/2020 | 686.52% | CICC | → 18.09 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
2020 年 12 月 2 日 | 679.57% | 中國文藝復興 | → 17.93 美元 | 啓動覆蓋開啓 | → 購買 |
02/11/2020 | 595.65% | 傑富瑞 | → 16 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for I-MAB (IMAB)?
I-MAB(IMAB)的目標價格是多少?
The latest price target for I-MAB (NASDAQ: IMAB) was reported by Needham on August 18, 2023. The analyst firm set a price target for $24.00 expecting IMAB to rise to within 12 months (a possible 943.48% upside). 9 analyst firms have reported ratings in the last year.
Needham於2023年8月18日公佈了I-MAB(納斯達克股票代碼:IMAB)的最新目標股價。該分析公司將目標股價定爲24.00美元,預計IMAB將在12個月內上漲至943.48%(可能上漲943.48%)。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for I-MAB (IMAB)?
I-MAB(IMAB)的最新分析師評級是多少?
The latest analyst rating for I-MAB (NASDAQ: IMAB) was provided by Needham, and I-MAB reiterated their buy rating.
I-MAB(納斯達克股票代碼:IMAB)的最新分析師評級由Needham提供,I-MAB重申了買入評級。
When is the next analyst rating going to be posted or updated for I-MAB (IMAB)?
I-MAB(IMAB)的下一個分析師評級將在何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of I-MAB, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for I-MAB was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.
分析師在進行了廣泛的研究後得出了股票評級,包括閱讀公開財務報表、與I-MAB的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。I-MAB的最後一次評級是在2023年8月18日提交的,因此你應該預計下一個評級將在2024年8月18日左右公佈。
Is the Analyst Rating I-MAB (IMAB) correct?
分析師評級 I-MAB (IMAB) 是否正確?
While ratings are subjective and will change, the latest I-MAB (IMAB) rating was a reiterated with a price target of $0.00 to $24.00. The current price I-MAB (IMAB) is trading at is $2.30, which is within the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但重申了最新的I-MAB(IMAB)評級,目標股價爲0.00美元至24.00美元。I-MAB(IMAB)目前的交易價格爲2.30美元,在分析師的預測區間內。